Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Mercury Biomed LLC currently has 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This single action is being reviewed within 1 distinct art unit, suggesting a focused application of the company's medical technology. The prosecution is being conducted by 1 distinct examiner, which allows for a direct and consistent line of communication with the patent office. For a practitioner, this indicates that the legal strategy can be narrowly tailored to the specific examination standards of this technical division.
The busiest examiner, BLAISE, BRADFORD CHRISTOPHER, is currently managing the 1 busiest examiner pending office action. With only 1 distinct examiner assigned to the portfolio, the company's immediate patenting goals are subject to the examination style of this single individual. The use of 1 distinct art unit indicates that the pending technology is specialized and does not overlap with other mechanical or medical classifications at this stage. This centralized prosecution profile minimizes the complexity often found in larger portfolios that span multiple art units and examiners, allowing for a highly targeted patenting strategy.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BLAISE, BRADFORD CHRISTOPHER | 1 | 60.7% | +31.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18472362 | DEVICES AND METHODS FOR SAFELY AND EFFECTIVELY RAISING OR MAINTAINING CORE BODY TEMPERATURE | BLAISE, BRADFORD CHRISTOPHER | 51d overdue |
| Art Unit | Apps |
|---|---|
| 3794 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18472362 | DEVICES AND METHODS FOR SAFELY AND EFFECTIVELY RAISING OR MAINTAINING CORE BODY TEMPERATURE | BLAISE, BRADFORD CHRISTOPHER | 3794 | §103 | Final Rejection | 51d overdue | Pending | Sep 22, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial